FrieslandCampina Ingredients opens new lactoferrin production facility 

The new sustainably built facility increases the company’s total lactoferrin capacity to 80 metric tonnes per year to help meet rising global demand.

The new plant located in Veghel, the Netherlands supports the production of lactoferrin, with fresh cow’s milk sourced through FrieslandCampina’s member farms

FrieslandCampina Ingredients has opened its new lactoferrin production facility in Veghel, the Netherlands, to meet demand in the early life and adult nutrition markets. The facility increases the company’s total capacity from 20 metric tonnes to 80 metric tonnes per year. The plant features new machinery supporting the production of lactoferrin and complies with the latest sustainability standards.

Innovative features

New equipment has been installed across the production process, from the collection of milk, to packaging and shipping, including technology for absorption and elution, filtration and spray drying. FrieslandCampina Ingredients also has access to fresh cow’s milk through its nearly 10,000 member farms.

FrieslandCampina Ingredients processes this milk into functional lactoferrin using a mild heat-treating process designed by the company’s R&D team. The result is a product that is 95% pure as a minimum and has considerable iron-binding properties.

In addition, the plant will run on green electricity generated by FrieslandCampina’s member farms and certified under the EU’s Guarantee of Origin scheme. Water and salt residues produced during the manufacturing process are reused. The facility will also adhere to the European Commission’s Best Available Techniques (BAT) guidelines for equipment design, build, maintenance and operation to comply with the latest sustainability standards.

Demand for lactoferrin

Multiple studies have demonstrated that lactoferrin, a protein naturally present in human milk and to a lesser extent in cow’s milk, can provide several health benefits, including supporting the body’s immune response and resilience to disease. These immune-supporting properties have made lactoferrin a popular ingredient in infant formula. It is also increasingly sought after for specialist adult nutrition applications.

Growing interest in lactoferrin has also been fuelled by an interest in the ingredient’s potential applications beyond immunity. As the volume of evidence demonstrating lactoferrin’s health benefits increases, and consumers increasingly seek out immune-supporting solutions, there is a surge in the development of new products to support multiple health areas for a range of consumers.

Prioritising health, quality and sustainability

Speaking on the opening of the new facility, Herman Ermens, president at FrieslandCampina Ingredients, said: “Today, the importance of supporting immunity for better health and holistic well-being is widely recognised. Taking steps to improve immune health is becoming a part of many people’s daily routines. I’m looking forward to seeing how our customers tap into the holistic well-being trend by offering their consumers new products that combine multiple health benefits in one convenient application. By expanding our production capacity and implementing new technologies, we’re not just meeting the growing demand for lactoferrin, but doing so in a way that prioritises both quality and sustainability. Over 25 years ago, we were one of the first companies producing lactoferrin and I’m proud to say we’re still leading innovation in this area to help people get the most out of life, always.”